Menu
Call for Abstracts: Share Your Research at the 9th SA TB Conference 2026.
The International Scientific Programme Committee invites you to submit an abstract for consideration for presentation at this upcoming international conference, to be held at the Emperors Palace, Johannesburg from 08–11 June 2026.
The deadline for abstract submissions has been extended to 13 February 2026. – Please ensure that your abstract is submitted before the deadline, as late submissions will not be considered.
Call for Abstracts: Share Your Research at the 9th SA TB Conference 2026.
Abstracts should be max 300 words Abstracts should be structured and include the following sections: background, objectives, methods, results, conclusions. For the co-design section, please include the description of how you engaged with communities, decision makers or other interest holders in your research Draft your abstract in text format in MS Word or a similar programme and copy and paste. Arial font size ten is advised Please submit your abstract in English. However, it is possible to present in French as translation services will be available. This can be arranged once the abstract is accepted. No graphic images, tables, graphs, or columns should be submitted with your abstract /presentation.
Conference Themes, Tracks and descriptors
The theme of the conference is “#Vuka! let’s unite towards a TB-free world!”
Abstracts will be reviewed according to the following tracks:
| Track | Theme | Description |
|---|---|---|
| 1 | Basic/translational and clinical sciences; including mechanisms of disease pathogenesis, genomics, host-pathogen interactions and diagnostics, lab to bench-side. | This track focuses on improving and expanding the understanding of TB basic and clinical sciences. This includes the mechanisms of TB infection and disease in humans and animals, host-pathogen interaction, resistance mechanisms, immunology, genetics, and biomarkers. The track also focuses on advances and innovations in TB diagnostics for drug-sensitive and drug-resistant TB and includes examples of cost-effective strategies and best practices for maximum benefit for different population groups (children, persons living with HIV, and other comorbidities). |
| 2 | Prevention, TB Vaccines, treatment strategies; including clinical trials; drug testing, lab to biotech partnerships | This track focuses on the latest advances and innovations in TB prevention and treatment including discovery, development, and implementation of new therapeutic and vaccination strategies. It also focuses on advances, challenges, innovations and best practices in active case finding and adopting treatment strategies with emerging novel short-course regimens for drug-sensitive TB, drug-resistant TB, and TB infection for children and adults. |
| 3 | Advances in Epidemiology and Health Systems | This track focuses on TB epidemiology and innovative delivery of TB services within the health system, the community and other settings. This track calls for research that actively integrates TB data, delivery, and impact. A key focus is on person-centred care for people with TB and other comorbidities including but not limited to HIV, mental health and other non-communicable diseases. This track aims to provide the latest evidence on cost-effective and innovative approaches to strengthening TB service delivery, with particular emphasis on digital health tools that enhance quality across the full care cascade. It also encompasses broader system-level components, including health systems strengthening, health promotion, environmental health, and robust monitoring and evaluation to drive measurable impact. |
| 4 | Sustainability in light of prevailing funding shortages | This track examines TB through a human-rights, people-centred, and sustainability lens. It focuses on identifying and addressing rights violations, stigma, discrimination, and structural barriers that hinder access to quality TB services, especially for key populations. The track highlights the role of civil society, communities, and affected groups in driving accountability, advocacy, and policy change, while showcasing patient and health worker experiences that reveal gaps and innovations across the care cascade. It also explores evidence-informed TB policy development and implementation aligned with national and global commitments. Given South Africa’s funding constraints, the track emphasises sustainable, cost-effective interventions and partnerships that strengthen long-term programme resilience and ensure equitable, impactful TB responses. |
Please note:
Submission Information Checklist:
Abstract Details
You will be required to complete the following fields:
CONTACTS
GENERAL QUERIES
Tel: +27 87 821 1109 / 012 110 4080
info@tbconference.co.za